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Abstract 
 Chronic sinusitis-rhinosinusiis affects 5-15 % of the urban population. The prevalence of sinusitis (146/1000 
population) has been reported to exceed that of any other chronic condition. The features of the disease Dushta 
Pratishyaya in general are similar to that of chronic sinusitis (rhinosinustis) in modern science. The study was 
planned to evaluate the role of Vyaghri Haritaki Avaleha and Anutaila Nasya in the management of Dushta 
Pratishyaya (Chronic Sinusitis). Total 30 patients having classical sign and symptoms of Dushta Pratishyaya 
(Chronic Sinusitis) were registered and were randomly divided into two groups (Group A- Vyaghri Haritaki 
Avaleha and Anutaila Nasya, Group B- Vyaghri Haritaki Avaleha). The patients were given Vyaghri Haritaki 
Avaleha for the duration of two months and Anutaila Nasya in 3 sittings of seven days in each with the interval of 
seven days. Total 26 patients completed the treatment, 13 in each. Obtained data was statistically analyzed with the 
help of student ‘t’ test. The study reveals that in both the groups no patient was totally cured. 46.15 % and 53.85 % 
patients got marked relief, 38.46 % and 23.08 % patients got moderate relief, 15.38% and 23.08 % patients got 
mild relief in signs and symptoms of the disease in Group A and B respectively. None of the patients remained 
unchanged. 
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Inroduction 
 Pratishyaya has been a major problem to the 
physicians since long back, this is because one 
separate chapter has been devoted to it after 
explaining Nasagataroga in Shusruta Samhita.(1) 
Unlike other nasal diseases, we get detailed 
description of Pratishyaya, with specific 
etiopathogenesis, classification, symptomatology, 
complications and management. 
 Pratishyaya by word itself indicates that it is 
recurrent in nature. Vata is the main Dosha and Kapha 
Pitta and Rakta are associated Dosha. (2) If these 
Dosha are vitiated more due to patient’s improper 
dietary and behavioral habits and if Pratishyaya is not 
managed properly, lead to a severe and complicated 
condition called Dushta Pratishyaya-which is very 
difficult to treat and causes lot of complications like 
Badhirya (Deafness), Andhata (Blindness), 
Ghrananasa (Anosmia) etc.(3) 
 The features of the disease Dushta Pratishyaya 
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in general are similar to that of chronic sinusitis 
(rhinosinustis) in modern science. 
 Nose is a sense organ which performs two 
functions i.e. olfactory and respiratory. Due to its direct 
contact with external environment it is exposed to lot of 
microorganisms & pollutants present in the atmosphere. 
Due to the increased environmental pollution, faulty 
lifestyle and decreased immunity; rhinitis (acute 
nonspecific rhinitis- common cold) is one of the most 
common acute infections affecting the body.(4) If this 
stage is not properly treated; it will cause the spread of 
infection into sinuses and results into sinusitis and later 
on chronic sinusitis (rhinosinusitis).(5) Chronic sinusitis 
is a long-term inflammation of the sinuses. It is 
diagnosed when symptoms of sinusitis persist for longer 
than 12 weeks despite treatment. Because of this, the 
mucous membranes in the nose and paranasal sinuses 
are constantly inflammed and become thickened. 
 Medical therapy is directed toward controlling 
predisposing factors, treating concomitant infections, 
reducing edema of sinus tissues, and facilitating the 
drainage of sinus secretions. The goal in surgical 
treatment is to re-establish sinus ventilation and to 
correct mucosal opposition in order to restore the 
mucociliary clearance system. Surgery strives to restore 
the functional integrity of the inflamed mucosal lining. 
 Many treatment modalities are propounded by 
ancient scholars for this disease according to condition 
of patient and progression of disease.(6) Though all 
Published online in http://ijam. co. in 
50 
Parth P Dave et.al., Management of Dushta Pratishyaya with Ayurvedic Oral Medication and Nasya 
ISSN: 0976-5921 
Acharya had described Dushta Pratishyaya as a 
complicated condition and with poor prognosis,(7) still 
a better management can be provided to the patient with 
internal and local medication without any side effects. 
 The places with high levels of atmospheric 
pollution, damp temperature climates with high 
concentration of pollens are associated with a higher 
prevalence of this disease. Jamnagar being known for 
Industrial pollution and having more dusty and humid 
environment, respiratory infections report a large 
number of cases. Approximately 50-60% of the ENT 
patients attending Shalakya O.P.D., have complaint of 
this Rhinitis and associated sinusitis. 
 Considering all these facts, a clinical trial on 
Dushta Pratishyaya was carried out to find out a 
treatment protocol for management of the same. For this 
study, Nasya with Anutaila and Vyaghri Haritaki 
Avaleha orally were selected. As Dushta Pratishyaya 
(Chronic Sinusitis) is a chronic condition of Dosha 
accumulation in particular Nasa and Shira; which 
happens   mainly due to Sanga type of Srotodushti; 
administration of Sneha Virechana Nasya of Anu Taila
(8) was selected for Dosha Sravana and Srotoshudhdhi. 
On the other hand, due to decreased immunity, 
recurrences are very common. According to Ayurveda, 
Rasayana can be used for improvement of immunity. So 
many Rasayana preparations are described in various 
texts, out of which Vyaghri Haritaki Avaleha (9) was 
selected for internal medication, as it is indicated for 
Peenasa (Chronic rhinitis/sinusitis) and also having 
Rasayana and anti-inflammatory effect. 
 
Aims and objectives 
To study the disease Dushta Pratishyaya (Chronic 
Sinusitis) in Ayurvedic and modern parlance. 
To assess the role of Anutail Nasya and Vyaghri 
Haritaki Avaleha in Dushta Pratishyaya (Chronic 
Sinusitis). 
 
Materials and methods  
Patient selection: 
 Patients attending the O.P.D. and I.P.D of 
Department of Shalakya (E.N.T. unit), were selected for 
the study, irrespective of their sex, religion, occupation, 
education etc. Total 30 patients were registered for the 
study. An elaborative case-taking proforma was 
specially designed for the purpose of incorporating all 
aspects of the disease on Ayurvedic and modern 
parlance. 
 Informed consent was taken from all the 
registered patients for the trial.  
 
Sampling technique: 
 A total no. of 30 patients were divided into two 
groups by simple random sampling method.  
 Study was started after getting ethical clearance 
from institutional ethics committee.  
 
Inclusion criteria 
 Patients fulfilling the diagnostic criteria which are 
based on symptomatology of Dushta Pratishyaya 
explained in Ayurvedic classics and chronic sinusitis 
were selected. 
 Subjective Criteria- Patients having symptoms of 
nasal discharge, nasal blockage, local pain, 
headache, nasal stuffiness, anosmia etc. 
 Objective criteria- Anterior rhinoscopic examination, 
Radiological examination of paranasal sinuses, nasal 
endoscopy, C-reactive protein test (CRP Test), 
hematological examination. 
 
Exclusion criteria 
 Patients aged below 12 years and above 70 years. 
 Chronic debilitating infectious diseases. 
 Cases which require surgical treatment. 
 
Investigations 
Following investigations were carried out before and 
after treatment. 
 Hematological examination: Hb%, TC, DC, ESR.  
 Urine examination: Routine and microscopic 
 Radiological examination of para nasal sinuses (X-
ray PNS (Waters view &     Caldwell’s view)). 
 Diagnostic nasal endoscopy. 
 
Grouping of patients 
 Group A - In this group patients were administered 
Vyaghri Haritaki Avaleha orally and Marsha Nasya 
with Anutaila. 
 Group B - In this group patients were administered 
Vyaghri Haritaki Avaleha orally. 
 
Drug and posology  
Preparatory phase: 
 Before starting the treatment, Deepana –Pachana 
with Trikatu Churna (3-5 gm. BD) and Koshtha 
Shudhdhi with Eranda Bhrishta Haritaki (5 gm at Bed 
time) was given for three days to all the patients. Before 
Nasya, Urdhava Jatrugata Abhyanga and Swedana was 
done as Purvakarma.  
 
Treatment phase: 
1.  Vyaghri Haritaki Avaleha 
Form: Avaleha. 
Route of Administration: Oral. 
Dose: 5 - 10gm/Two times a day after food with luke 
warm water. 
Duration: 2 months. 
 
2. Anutaila 
Form of Nasya Drug: Taila (Sneha). 
Route of Administration: Nose. 
Dose for Nasya: 8 drops in each nostril followed by 
Dhumpana. 
Duration: Nasya was given once daily for continue 
seven days. This was repeated thrice with interval of 
seven days in between. 
 
Assessment of total effect of therapy: 
 Complete relief: 100% relief in subjective and 
objective signs and symptoms 
 Marked relief: Above 75% relief in subjective 
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and objective signs and symptoms 
 Moderate relief: 51-75% relief in subjective and 
objective signs and symptoms 
 Mild relief: 26-50% relief in subjective and 
objective signs and symptoms 
 No relief: Below 25% relief in subjective and 
objective signs and symptoms 
Statistical Analysis: 
The effect of therapy in both the groups was 
assessed by applying student t test. The results obtained 
are considered highly significant for p<0.001, 
significant for p<0.01, p<0.05, and insignificant for 
p>0.05. 
 
Observations and Results: 
For this study total 30 patients were registered 
and randomly divided into two groups, among which 26 
patients (13 patients in each group) completed the 
treatment. 
Age:  
 Maximum number of the patients (40%) 
belonged to the age group of 20-29 years. While 30 % 
and 23.33 % patients were from the age group of 40-49 
years and 30-39 years respectively.  
 
Sex:  
 Majority of the patients were female i.e. 56.67% 
and rest patients were male i.e. 43.33 %.  
 
Surroundings:  
 Maximum number of the patients i.e. 63.33 % 
were from dusty surrounding followed by 30 % were 
from smoky and 23.33% were from polluted 
surroundings. 
 
Chronicity:  
 Maximum i.e. 46.67% patients were having 
chronicity of 1-5 years.33.33% patients were having the 
disease since 1 year. 20% were having chronicity of 5-
10 years. 
 
Nasal examination:  
 In nasal examination i.e. anterior rhinoscopy 
93.33 % patients were having Deviated Nasal Septum 
(DNS). 66.67 % patients had congestion. This is 
because of the body response to remove the retained 
discharge and also indicate a long standing 
inflammatory process. 60 % patients were having 
turbinate hypertrophy. 
 
Nasal discharge:  
 46.67 % patients had thick nasal discharge; 
followed by 30 % had yellow discharge. 23.33 % 
patients had watery discharge.13.33 % patients had 
purulent discharge.  
 
Sinus examination:  
 100 % patients had right and left maxillary sinus 
tenderness on examination, 76.67 % patients had right 
and left frontal sinus tenderness. On radiological 
examination 83.33 % patients had frontal sinusitis. 60 
% and 50 % patients had right and left maxillary 
sinusitis respectively. 
 
Table 1: Sinus examination wise distribution of 30 
patients 
A: Palpation: 
 
 
B:  Radiological: 
 
 
Nidana:  
 Maximum patients i.e. 60.33 % had Ajirna. 50 % 
patients had habit of Ati Ambu Pana and 43.33 % 
patients were doing Sheeta Ambu Pana. 56.67 % 
patients had exposure to Raja (dust).46.67 % patients 
were used to sleep in day times.70 % patients had short 
tempered nature. 
 
Chief and associated complaints:  
 Maximum i.e. 96.67 % patients had Shirashoola 
(headache) as their chief complaint. 86.67 % patients 
had Shirogaurava (heaviness in head). Shirashoola and 
Shirogaurava were observed as a characteristic feature 
of the disease. Majority of the patients i.e. 90 % and 
73.33 % patients had complaints of Nasavarodha (nasal 
obstruction) and Nasasrava (nasal discharge). 80 % 
patients had post nasal drip. Post nasal drip will result a 
lot of descending infections like pharyngitis, laryngitis, 
coughing etc. 
Sinuses 
No. of patients 
Total % 
Group 
A 
Group 
B 
Frontal 
Rt 15 15 30 76.67 
Lt 15 15 30 76.67 
Maxillary 
Rt 12 11 23 100 
Lt 12 11 23 100 
Ethmoid 
Rt 9 7 16 53.33 
Lt 8 7 15 50 
Sinuses 
No. of patients 
Total % 
Group 
A 
Group 
B 
Frontal 
Rt 13 12 25 83.33 
Lt 14 11 25 83.33 
Maxillary 
Rt 12 6 18 60 
Lt 9 6 15 50 
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Table 2: Chief and associated complaint wise 
distribution of 30 patients 
 
 
Effect of therapies on subjective symptoms (13 
patients in each group) 
Nasasrava was reduced in 80.77 % patients in 
Group A (p<0.001), while 88.22 % patients in Group B 
(p<0.01).  
Nasaavarodha was reduced in 66.46 % patients 
in Group A, while 84.21 % patients in Group B. Both 
these values are statistically highly significant 
(p<0.001). 
Shirashoola was reduced in 72.73 % patients in 
Group A, while 75.86 % patients in Group B. Both 
these values are statistically highly significant 
(p<0.001). 
In Gandhagyanata 50 % relief was observed in 
Group A which is statistically significant (p<0.05) and 
42.86 % relief was found in Group B which is 
statistically not significant (p>0.05). 
Mukhadaurgandhya was reduced in 100 % of 
Complaints 
No. of patients 
Total % Group 
A 
Group 
B 
Nasasrava 
(Nasal 
discharge) 
12 10 22 73.33 
Nasa Avrodha 
(Nasal 
blockage) 
12 15 27 90 
Gandha 
Agyanata 
(Anosmia) 
5 6 11 36.67 
Mukha 
Daurgandhya 
(Halitosis) 
2 4 6 20 
Shirah Shoola 
(Headache) 
15 14 29 96.67 
Kasa 
(Coughing) 
2 8 10 33.33 
Jwara  
(Fever) 
9 13 22 73.33 
the patients in group A and 71.43 % in Group B. 
Because of the less number this data couldn’t be 
analyzed statistically. 
In associated symptoms like Kasa and Jwara 100 
% relief was observed in both the groups. 
 
Table 3: Effect of therapies on chief and associated 
complaints in both the groups: 
 
 
Effect of therapy on examination of sinuses: 
Rt. maxillary sinus:  
 In 80 % patients in Group A and 75 % patients in 
Group B, relief was observed on tenderness of sinuses. 
Both these values are statistically highly significant 
(p<0.001). In 38.46 % patients in Group A and 25 % 
patients in Group B, haziness or opacity was reduced on 
radiological examination. Among these, the result of 
Group A is statistically significant (p<0.05) but in case 
of Group B it is statistically not significant (p>0.05). 
 
Lt. maxillary sinuses:  
 In 85 % patients in Group A and 83.33 % patients 
in Group B, relief was observed on tenderness of 
sinuses. Both these values are statistically highly 
significant (p<0.001). In 60 % patients in Group A and 
33.33 % patients in Group B haziness or opacity was 
reduced on radiological examination. Among these, the 
result of Group A is statistically significant (p<0.01) but 
Complaint 
Group A Group B 
% 
relief 
P 
% 
relief 
P 
Nasasrava 80.77 <0.001 88.24 <0.01 
Nasaavrodha 66.46 <0.001 84.21 <0.001 
Gandha- 
Agyanta 
50 <0.05 42.86 >0.05 
Shirashoola 72.73 <0.001 75.86 <0.001 
Mukha 
daurgandhya 
100 - 71.43 - 
Kasa 100 - 100 - 
Jwara 100 - 100 - 
Table 4: Effect of therapies on sinus examinations: 
 
Sinuses 
Palpation 
Radiological 
Group A Group B Group A Group B 
% relief P % relief p % relief P % relief P 
Rt.Maxillary 80 <0.001 75 <0.001 38.46 <0.05 25 >0.05 
Lt.Maxillary 85 <0.001 83.33 <0.001 60 <0.01 33.33 >0.05 
Rt.Frontal 76.19 <0.001 81.25 <0.001 50 <0.05 25 >0.05 
Lt.Frontal 76.19 <0.001 81.25 <0.001 61.54 <0.05 10 >0.05 
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in case of Group B it is statistically not significant 
(p>0.05). 
 
Rt. frontal sinuses:  
 In 76.19 % patients in Group A and 81.25 % 
patients in Group B, relief was observed on tenderness 
of sinuses. Both these values are statistically highly 
significant (p<0.001). But Group B showed better 
result. In 50 % patients in Group A and 25 % patients in 
Group B haziness or opacity was reduced on 
radiological examination. Among these, the result of 
Group A is statistically significant (p<0.05) but in case 
of Group B it is statistically not significant (p>0.05). 
 
Lt. frontal sinuses:  
 In 76.19 % patients in Group A and 81.25 % 
patients in Group B, relief was observed on tenderness 
of sinuses. Both these values are statistically highly 
significant (p<0.001). But Group B showed better 
result. In 61.54 % patients in Group A and 10 % 
patients in Group B haziness or opacity was reduced on 
radiological examination. Among these, the result of 
Group A is statistically significant (p<0.05) but in case 
of Group B it is statistically not significant (p>0.05).  
 
Overall effect of therapies on subjective and 
objective parameters: 
 In both the groups no one was totally cured. In 
Group A 46.15 % patients and in Group B 53.85 % 
patients got marked relief in signs and symptoms of the 
disease. In Group A 38.46 % patients and in Group B 
23.08 % patients got moderate relief in signs and 
symptoms of the disease. In Group A 15.38 % patients 
and in Group B 23.08 % patients got mild relief in signs 
and symptoms of the disease. None of the patients 
remained unchanged. 
 
Table 5: Overall effect of therapy 
 
 
Discussion: 
Age and sex:  
 According to references chronic sinusitis can 
affect any age group, but young and middle age group 
persons are affected the most. In this study also the 
same observations were found. Both the sex are equally 
Overall 
effect 
Group A Group B 
Total 
% No.
of 
pt. 
% 
No.
of 
pt. 
% 
Complete 
relief 
0 0 0 0 0 
Marked 
relief 
6 46.15 7 53.85 50 
Moderate 
relief 
5 38.46 3 23.08 30.77 
Mild relief 2 15.38 3 23.08 19.23 
No relief 0 0 0 0 0 
affected from the disease but in present study female 
were affected more than male. 
 
Surroundings of residence and work place:  
 Most patients were from dusty, smoky or polluted 
environment; Rajah Sevana is one of the Sadyojanaka 
cause of Prtishyaya.  
 
Chronicity:  
 Maximum patients were having chronicity of 1-5 
years, and 20% were having chronicity of 5-10 years. 
This factor directly influences the prognosis.  
 
Nasal examination:  
 More than 90% of patients were having DNS, 
DNS is a factor which plays a key role in blocking of 
the frontonasal duct (Frontal sinus ostium) and the ostia 
draining the ethmoid and maxillary sinuses which lead 
the sinusitis to a chronic phase. Majority of the patients 
were having turbinate hypertrophy that plays a major 
role in the blockage of sinus ostia which hampers the 
natural drainage system, resulting in sinusitis. 
 
Nasal discharge:  
 Majority of the patients were having thick-
yellowish or purulent nasal discharge, except 23.33% 
patients having watery nasal discharge. This data 
supports the fact that in Dushta Pratishyaya there will be 
Puyopam- Grathita Srava.(10) 
 
Sinus examination:  
 All the observations point out that anterior group 
of sinuses are affected more than posterior group. 
Fronto-maxillary sinusitis was the most common variety 
found in this study. Amongst 30 patients 53.33% and 50 
%   patients had right and left ethmoid sinus tenderness 
respectively. But with X-ray Water’s view of paranasal 
sinuses to rule out ethmoid sinusitis was not possible. 
 
Nidana:  
 Majority of the patients were having Ajeerna, 
most of patients were having habit of Ati Jalapana and 
Shitambu Sevana. Aharaja Nidana are reflection of the 
changing and busy lifestyle which played a role in the 
pathogenesis of the disease. Most of patients were 
having, Viharaja Nidana like Ritu Vaishamya, Raja, 
Dhuma Sevana etc. they are unavoidable etiological 
factors which are described by Acharya Sushruta as 
Sadyojanaka Nidana for Pratishayaya. Chronic contact 
with such unavoidable Nidana will nullify the effect of 
the therapy. It can be one reason why the patients were 
not getting relief even after taking treatment for years. 
Krodha as Manasika Nidana is also reflection of the 
Prakriti of the patients and also today’s lifestyle. This 
also plays a major roon le in the etiopathogenesis of the 
disease. 
 
Chief and associated complains:  
 The inflammation of nasal and sinus mucosa 
causes hyperemia, exudation of fluid and increased 
activity of serous and mucous glands. This causes nasal 
discharge. Increased blood flow due to infection causes 
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oedema of nasal and sinus mucosa which results in 
nasal obstruction. Deviated Nasal septum and 
hypertrophied turbinates worsen the conditions like 
Nasasrava and Nasavarodha. 
 
Effect of therapy on chief and associated complains: 
 In both the group statistically significant relief 
was observed in Nasasrava, Nasaavarodha and 
Shirashoola like symptoms. Oral drug administration of 
Vyaghri Haritaki Avaleha helped in reduction of 
inflammation and infection, and thus relieved 
Nasaavarodha due to oedema and Nasasrava due to 
infection and over activity of mucous secreting glands. 
When both inflammation and infection are checked; the 
sinuses get proper drainage and ventilation. As a 
consequence Shirshoola was reduced. In symptom of 
Gandhagyanta significant result was not found in group 
B. Smell perception is done by olfactory receptors 
situated at olfactory bulb. If the smell perception is 
obstructed due to oedema of mucosal linning, it can be 
restored by reducing inflammation. But if the olfactory 
epithelium is destroyed once cannot be restored. In 
group A Nasya was given which acts locally and helped 
in reduction of oedema. Thus in the symptom of 
Gandha Agyanta Group A showed better result. 
Associated symptoms like Kasa, Jwara and 
Mukhadaurgandhya were cured with the treatment of 
main disease. 
 
Effect of therapy on sinus examination:  
 On the above data, we can see that subjectively 
both the groups showed statistically significant 
improvement but objectively Group A showed 
statistically significant result while Group B didn’t 
show statistically significant improvement. This 
happened because of Nasya Karma, as drainage of 
retained secretions is facilitated by local Swedana and 
Aushdha instillation. This helps in early and better 
improvement in local pathology. 
 
Overall effect of therapy:  
 Maximum numbers of patients got marked relief. 
In both the groups none of the patient was totally cured, 
this is because the etiological factors of the disease are 
such as dust, moisture, wind, smoke, pollution, pollens 
etc. These are unavoidable environmental factors which 
cannot be completely avoided. So if the exposure to 
Nidana is continuous simultaneously with Chikitsa one 
cannot get proper or desired result. The result also 
depends upon the chronicity. In Ayurveda it is said that 
if the disease is chronic (Purana) it is difficult to treat- 
Yapya(8). Moreover the patients’ lowered immunity 
status is also one of the causes. It may require long time 
to boost up the immunity to fight against recurrences.  
The variation of results also depends upon Roga 
Bala, Rogi Bala and the Bhishagvashyata-compliance/
obedience of the patient. 
 
Probable mode of action of Vyaghri Haritaki 
Avaleha 
 Two main ingredients of Vyaghri Haritaki 
Avaleha are Haritaki and Kantkari. Haritaki has 
Tridoshshamaka property and Kantkari has Kapha-
Vatahara property. Both the drugs have Kapha-
Vatahara properties. Kantkari is an immunostimulating 
agent.(11) Haritaki also has immunomodulatory 
activity.(12) Haritaki is having Shothahara and 
Rasayana property also. Medicines of the Rasayana 
group are believed to promote health, immunity, and 
longevity.  Prakshepa Dravyas-Trikatu and Chaturjata 
have Ushna- Tikshna properties, which promote Agni, 
indirectly help in absorption and metabolism of active 
principles. Trikatu helps to increase the bioavailability 
of the medicine and more over removes the Srotorodha 
at the cellular level. Trikatu is the best bioavailability 
enhancers, which helps in maintaining the major 
therapeutic principles in the systemic circulation for 
longer duration and they are good Anulomana, Deepana 
and Pachana Dravyas and subsides the aggravated Vata. 
Trikatu possesses potential immunomodulatory activity 
and has therapeutic potential for the prevention of 
autoimmune diseases. (13) Madhu has Kaphahara and 
Chhedana properties. Guda is also used in this 
formulation and Haritaki with guda is said to be 
Tridoshahara. 
 Anti-inflammatory activity of Terminalia chebula 
Retz. was at least in part due to its modulatory effect on 
pro-inflammatory cytokine expression in the 
inflammation.(14) Antibacterial Activity of 
Hydroalcoholic Extract of Terminalia chebula Retz. on 
different Gram-positive and Gram-negative Bacteria is 
also well documented. (15) This resolves infection and 
inflammation and removes obstruction at sinus ostia & 
also liquifies stagnant discharge in sinuses, thus 
facilitates drainage. 
  Thus the formulation Vyaghri Haritaki Avaleha 
acts by rectifying Vayu by Ushna Veerya, Madhura 
Rasa, Anulomana property and Sroto-Shodhana by its 
Katu- Tikta-Kashaya Rasa, Ushna Veerya and Katu 
Vipaka, thus breaking the Samprapti. It will open the 
obstructed path like sinus ostia and facilitate the 
drainage of collected discharge. The formulation is 
having qualities like Madhura Rasa, which increases the 
Bala (strength) which is usually decreased in chronic 
condition, thus improving the condition of the patient. 
 
Probable mode of action of Anutaila Nasya 
 Instead of detailed description of the mode of 
action of Nasya Karma, Acharya Charaka and 
Vagbhatta have given some details regarding it. They 
mentioned that the medicine administrated through 
Nasya can easily spread into Shira and get absorbed 
and eliminates the Dosha from Urdhva Jatrugata 
Pradesha. Urdhvajatrugata Abhyanga and Swedana are 
done before Nasya. These pre procedural measures help 
in facilitating drug absorption. The drug administration 
is done in head low position, which plays a major role in 
retaining the instilled medicine in the nasopharynx, thus 
increasing the contact time with mucosa. After the 
absorption of the drug it may follow neural (olfactory 
and trigeminal) and circulatory (cavernous sinus) course 
to reach the site of action. It can influence the psychic 
level (limbic system), sensory level, motor level 
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(Trigeminal nerve) and general circulation and 
ultimately produce the action. (Excitation or sedation). 
 Due to Sukshama-Vyavayi Guna and special 
preparatory process, Anutaila possess a good spreading 
capacity through minute channels.  Tikta- Katu Rasa, 
Laghu- Tikshna Guna, Ushna Veerya and Katu- Vipaka 
make Srotoshodakatwa. By the above two properties 
the Nasya drug removes the obstruction of natural sinus 
ostia and facilitate the drainage of purulent discharge. 
Indriyadardhyakaratwa, Balya, Preenana and 
Brimhana properties can increase general and local 
immunity. Madhura Rasa, Sheeta Veerya, Snigdha 
Guna and Tridoshahara properties will promote the 
nourishment of Dhatu which ultimately increases the 
general and local immunity (mucosal health). This 
immunomodulation will reduce the frequent episodes of 
inflammation in nasal cavity and sinuses. Majority of 
ingredients possess anti-inflammatory activity which 
also prevent the inflammatory process. The local 
irritation made by the drug is helpful to liquefy the 
purulent sputum and ultimately expulsion. The 
bacteriostatic property of ingredients will arrest the 
secondary infection. 
 
Conclusion: 
Recurrent attack of Pratishyaya continue for 
months and years, will turn in to a chronic phase with 
much complication called Dushta Pratishyaya. On the 
basis of similarity between the signs, symptoms, 
complications, prognosis and chronicity, chronic 
sinusitis can be correlated with Dushta Pratishyaya. 
Both the group showed almost equal results in 
different symptoms. But objectively Group-A (Vyaghri 
Haritaki Avaleha with Anutaila Nasya) showed better 
result. So it can be said say that Nasya with oral 
medication may be much beneficial for early cure of 
the disease. 
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